Syrian Arab Republic vs Tajikistan: Share of deaths from cardiovascular diseases by sex
Syrian Arab Republic
48.4%
in 2010
Tajikistan
46.5%
in 2022
Syrian Arab Republic rank
12th
Tajikistan rank
13th
Share of deaths from cardiovascular diseases by sex over time
- Syrian Arab Republic
- Tajikistan
How they compare
Syrian Arab Republic currently reports 48.4% against 46.5% in Tajikistan, a difference of 1.9%.
The two have swapped places 2 times across 8 shared years of data; in 1998 it was Syrian Arab Republic ahead.
Syrian Arab Republic ranks 12th and Tajikistan ranks 13th of 113 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Syrian Arab Republic | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.7% | 38.0% | 1.7% | Syrian Arab Republic |
| 2000s | 47.2% | 44.5% | 2.7% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of deaths from cardiovascular diseases by sex, Syrian Arab Republic or Tajikistan?
- Syrian Arab Republic, at 48.4% against 46.5% in Tajikistan as of 2010.
- What is the difference in share of deaths from cardiovascular diseases by sex between Syrian Arab Republic and Tajikistan?
- 1.9%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Syrian Arab Republic and Tajikistan?
- 8 years are reported by both, from 1998 to 2005.
- How do Syrian Arab Republic and Tajikistan rank globally for share of deaths from cardiovascular diseases by sex?
- Syrian Arab Republic ranks 12th and Tajikistan ranks 13th of 113 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Share of deaths from cardiovascular diseases by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of total reported deaths in males in those aged all ages that are from cardiovascular diseases.